Market Research Report

Global Cannabidiol Market Report By Product (Food Grade And Therapeutic Grade), By Application (Neurogenerative Disorder, Fibromyalgia, Diabetes And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2021-2028

ID:VMR11210267
April 2021
Report Formats: Report Formats

Rising demand from the healthcare sector to cure chronic and neurogenerative disorders are driving the market growth. Increasing count of the population suffering with bipolar disorder, Alzheimer and multiple sclerosis is further boosting the cannabidiol demand. In addition to this, growing popularity owing to wellness ingredient is spurring the market growth. The rising number of players owing to more relaxed legislation on the usage of cannabidiol in sports nutrition, medicines, cosmetics, and pet care product has triggered the market growth. In relation to this, approval of cannabidiol as a first oral drug by FDA for a rare and severe form of epilepsy is again boosting the market grow.

The latest report by Value Market Research expects the Global Cannabidiol Market to reach USD 10,280.2 million by 2025. It was valued USD 1,396.5 million in 2018. The report foresees a 33% CAGR from 2019 to 2025.
 
PHARMACEUTICAL GRADE DOMINATED THE PRODUCT SEGMENT
In 2018, pharmaceutical grade emerged as the leading product segment by accounting major share. Use of cannabidiol based medicines for curing bipolar disorder, epilepsy, Alzheimer and other neurological disorders are driving its demand. Also, rising application of cannabidiol in oils, powders, supplements, & high concentration extracts to cure other aliment is again boosting the market growth.
 
BY APPLICATION, FIBROMYALGIA LED THE SEGMENT
Fibromyalgia has dominated the application segment in 2018 owing to the rising count of patients suffering from physical or emotional trauma, physiological stress, and surgery are driving the segment growth.  Along with this, lack of exercise, sedentary lifestyle, poor diet and improper sleep cycle are some of the prominent factors driving the segment growth.
 
NORTH AMERICA HELD THE LARGEST MARKET SHARE
North America has dominated the regional market in 2018. Growing geriatric population followed by rising in patients’ with neurogenerative, musculoskeletal and other aliments are driving the demand of cannabidiol-based drugs. Also, the rise in cultivation of marijuana plants, a result of liberal policies on the sale of cannabidiol is again pushing the regional market growth uphill.
 
KEY PLAYERS OF THE MARKET
Aurora Cannabis, Canopy Growth Corporation, CBD American Shaman, CV Sciences (CV Sciences, Inc.), Elixinol, Folium Biosciences, Gaia Botanicals (Gaia Botanicals LLC), IRIE CBD, Isodiol (Isodiol International Inc), NuLeaf Naturals (NuLeaf Naturals, LLC.) and PharmaHemp (Pharmahemp d.o.o.) are some of the major players of cannabidiol market.

As per this study the Global Cannabidiol Market was valued USD XX MN (by revenue) in 2021 and is anticipated to reach USD XX MN by 2028 with a CAGR of XX%.
 
Cannabidiol (CBD) is a phytocannabinoid compound extracted from cannabin sativa plant or marijuana. Cannabidiol is anti-inflammatory, anti-oxidant, analgesic compound that act as neuro and immunoprotector in various medical conditions. CBD is used in potential treatment to cure epilepsy, fibromyalgia, chronic polyarthritis, and Neurogenerative conditions such as Parkinson’s disease, multiple sclerosis and others.
 
Market Dynamics
 
Rising prevalence of Neurogenerative disorders such as dystonia, Alzheimer diseases, multiple sclerosis and others is driving the demand of CBD for medicinal purpose. Growing popularity owing to wellness ingredient is pushing the market growth. Approval of cannabidiol as a first oral drug by FDA for rare and severe form of epilepsy is again boosting the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of cannabidiol.
 
Market Segmentation
 
The broad cannabidiol market has been sub-grouped into product and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Product
  • Food Grade
  • Therapeutic Grade
 
By Application
  • Neurogenerative Disorder
  • Fibromyalgia
  • Diabetes
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for cannabidiol in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Global Cannabidiol Market Share by Region (Representative Graph)
 
Global Cannabidiol Market Share
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the cannabidiol market includes Aurora Cannabis, Canopy Growth Corporation, CBD American Shaman, CV Sciences (CV Sciences, Inc.), Elixinol, Folium Biosciences, Gaia Botanicals (Gaia Botanicals LLC), IRIE CBD, Isodiol (Isodiol International Inc), NuLeaf Naturals (NuLeaf Naturals, LLC.) and PharmaHemp (Pharmahemp d.o.o.). An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . CANNABIDIOL – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Product
           3.7.2 Market Attractiveness Analysis By Application
           3.7.3 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL CANNABIDIOL MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Historical and Forecast Data
       6.3 Analysis by Product
       6.4 Food Grade Historic and Forecast Sales by Regions
       6.6 Therapeutic Grade Historic and Forecast Sales by Regions
 
7 . GLOBAL CANNABIDIOL MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Historical and Forecast Data
       7.3 Analysis by Application
       7.4 Neurogenerative Disorder Historic and Forecast Sales by Regions
       7.5 Fibromyalgia Historic and Forecast Sales by Regions
       7.6 Diabetes Historic and Forecast Sales by Regions
       7.7 Others Historic and Forecast Sales by Regions
 
8 . GLOBAL CANNABIDIOL MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America Sales Analysis
           8.3.1. Overview, Historic and Forecast Sales Analysis
           8.3.2. North America By Segment Sales Analysis
           8.3.3. North America By Country Sales Analysis
           8.3.4. United State Sales Analysis
           8.3.5. Canada Sales Analysis
           8.3.6. Mexico Sales Analysis
       8.4. Europe Sales Analysis
           8.4.1. Overview, Historic and Forecast Sales Analysis
           8.4.2. Europe by Segment Sales Analysis
           8.4.3. Europe by Country Sales Analysis
           8.4.4. United Kingdom Sales Analysis
           8.4.5. France Sales Analysis
           8.4.6. Germany Sales Analysis
           8.4.7. Italy Sales Analysis
           8.4.8. Russia Sales Analysis
           8.4.9. Rest Of Europe Sales Analysis
       8.5. Asia Pacific Sales Analysis
           8.5.1. Overview, Historic and Forecast Sales Analysis
           8.5.2. Asia Pacific by Segment Sales Analysis
           8.5.3. Asia Pacific by Country Sales Analysis
           8.5.4. China Sales Analysis
           8.5.5. India Sales Analysis
           8.5.6. Japan Sales Analysis
           8.5.7. South Korea Sales Analysis
           8.5.8. Australia Sales Analysis
           8.5.9. Rest Of Asia Pacific Sales Analysis
       8.6. Latin America Sales Analysis
           8.6.1. Overview, Historic and Forecast Sales Analysis
           8.6.2. Latin America by Segment Sales Analysis
           8.6.3. Latin America by Country Sales Analysis
           8.6.4. Brazil Sales Analysis
           8.6.5. Argentina Sales Analysis
           8.6.6. Peru Sales Analysis
           8.6.7. Chile Sales Analysis
           8.6.8. Rest of Latin America Sales Analysis
       8.7. Middle East & Africa Sales Analysis
           8.7.1. Overview, Historic and Forecast Sales Analysis
           8.7.2. Middle East & Africa by Segment Sales Analysis
           8.7.3. Middle East & Africa by Country Sales Analysis
           8.7.4. Saudi Arabia Sales Analysis
           8.7.5. UAE Sales Analysis
           8.7.6. Israel Sales Analysis
           8.7.7. South Africa Sales Analysis
           8.7.8. Rest Of Middle East And Africa Sales Analysis
 
9 . COMPETITIVE LANDSCAPE OF THE CANNABIDIOL COMPANIES
       9.1. Cannabidiol Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF CANNABIDIOL INDUSTRY
       10.1. Top 10  Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Aurora Cannabis
           10.3.1. Company Overview
           10.3.2. Company Revenue
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Canopy Growth Corporation
           10.4.1. Company Overview
           10.4.2. Company Revenue
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. CBD American Shaman
           10.5.1. Company Overview
           10.5.2. Company Revenue
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. CV Sciences (CV Sciences, Inc.)
           10.6.1. Company Overview
           10.6.2. Company Revenue
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Elixinol
           10.7.1. Company Overview
           10.7.2. Company Revenue
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Folium Biosciences
           10.8.1. Company Overview
           10.8.2. Company Revenue
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Gaia Botanicals (Gaia Botanicals LLC)
           10.9.1. Company Overview
           10.9.2. Company Revenue
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. IRIE CBD
           10.10.1. Company Overview
           10.10.2. Company Revenue
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Isodiol (Isodiol International Inc)
           10.11.1. Company Overview
           10.11.2. Company Revenue
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. NuLeaf Naturals (NuLeaf Naturals, LLC.)
           10.12.1. Company Overview
           10.12.2. Company Revenue
           10.12.3. Products
           10.12.4. Recent Developments
       10.13. PharmaHemp (Pharmahemp d.o.o.)
           10.13.1. Company Overview
           10.13.2. Company Revenue
           10.13.3. Products
           10.13.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

 LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Product (USD MN)
  •  Food Grade Market Sales by Geography (USD MN)
  •  Therapeutic Grade Market Sales by Geography (USD MN)
  •  Analysis Market by Application (USD MN)
  •  Neurogenerative Disorder Market Sales by Geography (USD MN)
  •  Fibromyalgia Market Sales by Geography (USD MN)
  •  Diabetes Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Cannabidiol Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
 
 
 LIST OF FIGURES
 
  •  Research Scope of Cannabidiol Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Cannabidiol Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Product
  •  Market Attractiveness Analysis by Application
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis Product (USD MN)
  •  Food Grade Market Sales by Geography (USD MN)
  •  Therapeutic Grade Market Sales by Geography (USD MN)
  •  Global Market Analysis by Application (USD MN)
  •  Neurogenerative Disorder Market Sales by Geography (USD MN)
  •  Fibromyalgia Market Sales by Geography (USD MN)
  •  Diabetes Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top 10  Company Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials